Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 12;14(6):1456.
doi: 10.3390/cancers14061456.

What Do We Know about Survival in Skeletally Premature Children Aged 0 to 10 Years with Ewing Sarcoma? A Multicenter 10-Year Follow-Up Study in 60 Patients

Affiliations

What Do We Know about Survival in Skeletally Premature Children Aged 0 to 10 Years with Ewing Sarcoma? A Multicenter 10-Year Follow-Up Study in 60 Patients

Sarah E Bosma et al. Cancers (Basel). .

Abstract

(1) Background: Younger age has been associated with better overall survival (OS) in Ewing sarcoma (ES), especially under the age of 10. The favorable survival in younger patients underlines the need for minimizing treatment burden and late sequelae. Our study aimed at describing clinical characteristics, treatment and outcome of a cohort of ES patients aged 0−10. (2) Methods: In this retrospective multicenter study, all consecutive ES patients aged 0−10, treated in four sarcoma centers in the Netherlands (n = 33) and one in Spain (n = 27) between 1982 and 2008, with a minimum follow-up of 10 years, were included. OS, local recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS) were calculated. Potential factors of influence on OS (risk and protective factors) were analyzed. (3) Results: 60 patients with median follow-up 13.03 years were included. All patients were treated with chemotherapy in combination with local treatment, being surgery alone in 30 (50%) patients, radiotherapy (RT) alone in 12 (20%) patients or surgery plus RT in 18 (30%) patients (12 pre- and 6 postoperative). Limb salvage was achieved in 93% of patients. The 10-OS, -LRFS and -DMFS are 81% (95% CI: 71−91%), 89% (95% CI: 85−93%) and 81% (95% CI: 71−91%), respectively. Six patients developed LR, of which two developed subsequent DM; all had axial ES (pelvis, spine or chest wall), and these patients all died. Ten patients developed DM; eight died due to progressive disease, and two are currently in remission, both with pulmonary metastasis only. Negative or wide resection margin was significantly associated with better OS. Age < 6 years, tumor volume < 200 mL, absence of metastatic disease and treatment after 2000 showed trends towards better OS. Two patients developed secondary malignancy; both had chemotherapy combined with definitive RT for local treatment. (4) Conclusions: Overall survival of these youngest patients with ES was very good. Limb salvage surgery was achieved in >90% of patients. Wide resection margin was the only factor significantly associated with better survival.

Keywords: Ewing sarcoma; distant metastasis; local recurrence; long-term outcome; pediatric; secondary malignancy; survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Kaplan–Meier curves for age (A), tumor volume (B), metastasis at diagnosis (C), tumor location (D), surgical margin (E) and treatment era (F).

Similar articles

Cited by

References

    1. Fletcher C.D.M., Hogendoorn P.W.C., Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. IARC; Lyon, France: 2013.
    1. Arora R.S., Alston R.D., Eden T.O., Geraci M., Birch J.M. The contrasting age-incidence patterns of bone tumours in teenagers and young adults: Implications for aetiology. Int. J. Cancer. 2012;131:1678–1685. doi: 10.1002/ijc.27402. - DOI - PubMed
    1. Duchman K.R., Gao Y., Miller B.J. Prognostic factors for survival in patients with Ewing’s sarcoma using the surveillance, epidemiology, and end results (SEER) program database. Cancer Epidemiol. 2015;39:189–195. doi: 10.1016/j.canep.2014.12.012. - DOI - PubMed
    1. van den Berg H., Kroon H.M., Slaar A., Hogendoorn P. Incidence of biopsy-proven bone tumors in children: A report based on the Dutch pathology registration “PALGA”. J. Pediatr. Orthop. 2008;28:29–35. doi: 10.1097/BPO.0b013e3181558cb5. - DOI - PubMed
    1. Whelan J., McTiernan A., Cooper N., Wong Y.K., Francis M., Vernon S., Strauss S.J. Incidence and survival of malignant bone sarcomas in England 1979–2007. Int. J. Cancer. 2012;131:E508–E517. doi: 10.1002/ijc.26426. - DOI - PubMed

LinkOut - more resources